Perspectives

The future of gene targeting in treating Parkinson’s disease

Comparing the research behind Alzheimer’s and Parkinson’s disease treatments

Bringing plasma biomarkers into clinical practice: what does the future hold?

Beyond Aβ and p-Tau: novel biomarkers under investigation for Alzheimer’s disease

The potential of NfL as a biomarker in neurodegenerative diseases

Highlights from AAIC: Targeting the immune response to treat AD

AAIC 2021 highlights in the vascular space

The contribution of vascular disease to cognitive impairment and Alzheimer’s pathology

Animal models of vascular contributions to cognitive impairment and dementia

Endothelial biomarkers for vascular contributions to dementia

Understanding brain health disparities

The exposome: a rapidly emerging field

Approval of aducanumab for Alzheimer’s disease

The challenges of Alzheimer’s disease animal models and the use of human stem cells

Identifying innate immune system genes linked to AD

Retinal imaging techniques and their applications on Alzheimer’s disease research